Clinical trial
Refocusing On Morphine: Myocardial Protection Versus Fentanyl Via Pharmacological Conditioning In Acyanotic Pediatric Cardiac Surgery - A Randomized Controlled Trial
NCT07839273 is registered in ClinicalTrials.gov with Baskent University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Refocusing On Morphine: Myocardial Protection Versus Fentanyl Via Pharmacological Conditioning In Acyanotic Pediatric Cardiac Surgery - A Randomized Controlled Trial
- Lead sponsor
- Baskent University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 2, 2022
- Completion date
- September 20, 2023
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.